Refine Results
  1. "JAMA Oncology"
Formats
  1. Journal Article (173)
  2. Correspondence (21)
  3. Editorial (20)
  4. Review (13)
  5. Research Letter (6)
  6. Guidelines (3)
Groups
  1. Department of Medicine (140)
  2. Solid Tumor Oncology Division (109)
  3. Survivorship Research (61)
  4. Population Sciences Research Program (51)
  5. Surgery (47)
  6. Epidemiology and Biostatistics (44)

More Groups

People
  1. Monica Morrow (14)
  2. Howard Scher (10)
  3. Leonard Saltz (10)
  4. Sham Mailankody (10)
  5. Carl Landgren (9)
  6. Mithat Gonen (9)

More People

Years
  1. 2022 (10)
  2. 2021 (35)
  3. 2020 (42)
  4. 2019 (33)
  5. 2018 (42)
  6. 2017 (27)

More Years

Publications
  1. JAMA Oncology (236)
Publishers
  1. American Medical Association (236)

Results (236)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis
    Journal Article

    Lowry, K. P.; Geuzinge, H. A.; Stout, N. K.; Alagoz, O.; Hampton, J.; Kerlikowske, K.; de Koning, H. J.; Miglioretti, D. L.; van Ravesteyn, N. T.; Schechter, C.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Evidence-based clinical practice guidelines for extramammary Paget disease
    Guidelines

    Kibbi, N.; Owen, J. L.; Worley, B.; Wang, J. X.; Harikumar, V.; Downing, M. B.; Aasi, S. Z.; Aung, P. P.; Barker, C. A.; Bolotin, D.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Examination of low ERBB2 protein expression in breast cancer tissue
    Journal Article

    Fernandez, A. I.; Liu, M.; Bellizzi, A.; Brock, J.; Fadare, O.; Hanley, K.; Harigopal, M.; Jorns, J. M.; Kuba, M. G.; Ly, A.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Early readout on overall survival of patients with melanoma treated with immunotherapy using a novel imaging analysis
    Journal Article

    Dercle, L.; Zhao, B.; Gönen, M.; Moskowitz, C. S.; Firas, A.; Beylergil, V.; Connors, D. E.; Yang, H; Lu, L.; Fojo, T.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus–associated oropharyngeal carcinoma treated with definitive chemoradiotherapy
    Journal Article

    Tsai, C. J.; McBride, S. M.; Riaz, N.; Kang, J. J.; Spielsinger, D. J.; Waldenberg, T.; Gelblum, D.; Yu, Y.; Chen, L. C.; Zakeri, K.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Carboplatin during craniospinal radiotherapy for children with group 3 medulloblastoma—A new standard of care?
    Editorial

    Karajannis, M. A.; Mauguen, A.; Kramer, K.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Final overall survival and molecular analysis in IMmotion151, a phase 3 trial comparing atezolizumab plus bevacizumab vs sunitinib in patients with previously untreated metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Powles, T.; Atkins, M. B.; Escudier, B.; McDermott, D. F.; Alekseev, B. Y.; Lee, J. L.; Suarez, C.; Stroyakovskiy, D.; De Giorgi, U.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • The urgent need for affordability curricula at US medical schools: The cost of avoiding cost for the next generation of physicians
    Editorial

    Patel, P. V.; Lacy, A. L.; Chino, F.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • When radiotherapy and immunotherapy dance—Who leads so as not to step on toes?
    Editorial

    Balogun, F.; Raben, D.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Implications of selection bias due to delayed study entry in clinical genomic studies
    Journal Article

    Brown, S.; Lavery, J. A.; Shen, R.; Martin, A. S.; Kehl, K. L.; Sweeney, S. M.; Lepisto, E. M.; Rizvi, H.; McCarthy, C. G.; Schultz, N.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save